Old CIC Events
30/04/2026
A portfolio of immunotherapies to treat ALK+ cancers
Roberto Chiarle — Department of Pathology (Boston Children's Hospital)
28/04/2026
Evaluating Next-Generation CAR-T Cells in Complex Tumor-Immune Models
Naiara Martínez-Vélez — Stanford University
17/04/2026
Defensa de tesis doctoral: C3G in chronic myeloid leukemia: linking disease progression in mouse models with cellular leukemogenic mechanisms
Pablo Berrocal — Programa de Doctorado: Biología y Clínica del Cáncer
16/04/2026
ZMYM3 and ZNF292 mutations in chronic lymphocytic leukemia: clinical and biological implications
Alberto Rodríguez Sánchez — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)
09/04/2026
Harnessing Post-Lactational Involution for Breast Cancer Prevention
Manuel Jesús Pérez Baena — Centro de Investigación del Cáncer (CSIC-USAL-FICUS)
19/03/2026
Fluorescence imaging of lipid trafficking pipelines in mammalian cells
Juan Manuel Iglesias Artola — Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), Germany
13/03/2026
Defensa de tesis doctoral: Papel de la señalización RAS–PI3K en la regulación del fenotipo y la función de los fibroblastos asociados a cáncer
Marta Alcón Pérez — Programa de doctorado Biología y Clínica del Cáncer
11/03/2026
RNA-binding proteins and translational control in cancer
Fátima Gebauer Hernández — Centre for Genomic Regulation (CRG, Barcelona, Spain)
05/03/2026
Immune dysregulation in monoclonal gammopathy and its implications for disease control and progression
Oihane Pérez Escurza — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)
19/02/2026
Proteomic approaches for disentangling oncogenic kinase signalling and for advancing personalized therapies
Pedro Rodríguez Cutillas — Instituto de Parasitología y Biomedicina López-Neyra (CSIC), Granada